| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $0.3B | $0.1B | $0.5B | $0.2B | $0.8B |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — |
| SG&A Expense | — | — | — | $0.7B | $0.3B | $0.3B |
| Operating Income | $-0.2B | $-0.1B | $-0.1B | $-0.1B | $-0.5B | $0.1B |
| Net Income | $0.0B | $-0.0B | $0.5B | $-0.1B | $-0.4B | $0.1B |
| EPS (Basic) | $0.93 | $-5.68 | $14.51 | $-3.00 | $-17.39 | $5.27 |
| EPS (Diluted) | $0.74 | $-5.68 | $14.40 | $-3.00 | $-17.39 | $0.72 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Total Assets | $4.2B | $4.8B | $5.0B | $5.5B | $4.3B | $3.7B |
| Current Assets | $0.8B | $0.9B | $0.6B | $1.2B | $1.4B | $1.4B |
| Cash & Equivalents | — | — | $0.1B | $0.8B | $1.2B | $0.9B |
| Total Liabilities | $2.0B | $2.4B | $2.4B | $3.4B | $1.7B | $0.8B |
| Current Liabilities | $0.7B | $1.4B | $0.7B | $1.0B | $0.7B | $0.5B |
| Stockholders' Equity | $2.2B | $2.4B | $2.6B | $2.0B | $2.4B | $2.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $-0.0B | $0.2B | $0.1B | $-0.3B | $0.1B |
| Investing Cash Flow | $-0.0B | $-0.0B | $-0.7B | $-0.8B | $-0.1B | $-0.4B |
| Capital Expenditures | — | — | — | $0.8B | $0.5B | $0.5B |
| Financing Cash Flow | $-0.2B | $0.2B | $0.1B | $-0.0B | $0.6B | $0.1B |